MedTech Spectrum

Article Name Medtech Thought Leader's

Japan's Olympus names Dr John de Csepel as Chief Medical Officer

Dr de Csepel joins Olympus from Medtronic, where he most recently served as the Global Regions Chief Medical Officer

09th October, 2023

“There is a need for more innovations in the way healthcare is delivered at the point-of-care level”

The reimagination of health systems in India is turning towards a central role being played by point-of-care tests that are accessible and affordable, to enable early detection and timely treatment of a number of diseases impacting India. This not only includes the current monsoon related spike in malaria cases that has surged by 40 per cent over last year's count, but also makes us reflect upon the fact that for the majority of tuberculosis (TB) testing, age-old microscopy technique still holds a major share. Addressing this demand for high-quality, point-of-care molecular diagnostic systems that is higher than ever today, Goa-based in-vitro diagnostic company Molbio Diagnostics is accelerating work on newer technologies. In conversation with MedTech Spectrum & BioSpectrum, Sriram Natarajan, Director and Chief Executive Officer, Molbio Diagnostics spoke in detail about the country’s healthcare challenges and the company’s contribution in attending to those challenges with novel ideas.

05th October, 2023

“Laws pertaining to protection of health data, informed consent and other data privacy related facets have to be enforced at a faster rate”

During mid-August 2023, The Robert Bosch Centre for Data Science and Artificial Intelligence (RBCDSAI) at The Indian Institute of Technology Madras’ (IIT Madras) organised the ‘Fifth AI/ML Conclave on Healthcare’ in collaboration with the Centre for Responsible AI (CeRAI) and Centre for Integrative Biology and Systems medicinE (IBSE). The event was designed to help the healthcare industry know what AI can bring to the table. One of the key mandates of RBCDSAI is to encourage wider adoption of AI and AI enabled services. At the event, team BioSpectrum India took the opportunity to speak with Prof. Balaraman Ravindran, Head, RBCDSAI and CeRAI, IIT Madras on his thoughts on Generative AI and harnessing its potential in healthcare.

05th October, 2023

Japan's Olympus names Dr John de Csepel as Chief Medical Officer

Dr de Csepel joins Olympus from Medtronic, where he most recently served as the Global Regions Chief Medical Officer

04th October, 2023

How blood-based protein biomarkers enable early detection and intervention of Alzheimer’s disease

Blood-based protein biomarkers have emerged as a promising tool for the early detection of Alzheimer's disease

11th September, 2023

"We are coming up with CoEs for health science & medical devices": Priyank Kharge

Priyank Kharge, Minster for IT BT, Government of Karnataka speaking at the Global Innovation Alliance (GIA) Partners Meet held on August 28, 2023 in Bangalore

07th September, 2023

Regulatory Landscape of In Vitro Fertilisation (IVF) Across Asia

According to the World Health Organisation (WHO) data, approximately one in every six couples worldwide is impacted by infertility.

06th September, 2023

“Policies that help to add value to the R&D ecosystem are essential to empower Indian medical device sector”

OMRON Healthcare Manufacturing India (a subsidiary of OMRON Healthcare Corporation Japan) has begun the construction of its new plant in Chennai in May 2023. Being built with an investment of Rs 128 crore, this state-of-the-art facility will mark the company’s debut in the healthcare manufacturing space in India and will further strengthen its presence in the home healthcare device industry in the country as well as its global network of production facilities with locations in Japan, China, Vietnam, Italy and Brazil. In conversation with BioSpectrum Asia & MedTech Spectrum, Tetsuya Yamada, Managing Director, OMRON Healthcare India talks about the company’s growth plans in Asia.

04th September, 2023

“We need policy frameworks to support import substitution opportunities for medical devices in government hospitals”

Industry veteran Prashant Krishnan recently joined Bengaluru-based Healthium Medtech as Global Business Head for Advanced Wound Care and Surgery at a time when Healthium plans to expand its presence in India and beyond. The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertise, as the company strives to achieve its strategic goals and vision of facilitating precision medtech for every patient globally. In an interaction with BioSpectrum & MedTech Spectrum , Krishnan reveals more about his goals to create a global company with a strong portfolio, impressive global footprint and an exceptional clinical and quality manufacturing team.

01st September, 2023

Indigenous MedTech Innovations Drive Cardiac Care

India has a long way to go when it comes to indigenously developing tools for cardiac care. Though there has been significant improvement in manufacturing and global players tying up with Indian players, it is a long journey ahead. Artificial Intelligence (AI) and Machine learning-based tools are being touted as the future of cardiac care devices in the country.

01st September, 2023

“Stricter regulations can impede timely approvals and adoption of advanced technologies”

Fujifilm India, the Indian arm of Japan-headquartered company Fujifilm, has announced the first-ever installation of the new Magnetic Resonance Imaging (MRI) machine Echelon Smart 1.5 Tesla in India. As the Medical Systems business thrives, Fujifilm India plans to increase its contribution towards improving the healthcare system in India. In a detailed interaction with BioSpectrum, Chander Shekhar Sibal, Head, Healthcare Division, Fujifilm India expounds about the new product and its impact on the Indian medtech sector.

01st September, 2023

Elevating Nursing as a Prestigious Career Choice

It is crucial to promote a more comprehensive understanding of the vital role that nursing professionals play in healthcare

08th August, 2023

“Asia-Pacific represents a vast and relatively untapped market for Digital Pathology”

JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis. Dr Yen-Yin Lin, CEO of JelloX Biotech, highlights this new era in digital pathology, unveils the company's growth plans, strategic partnerships, and significant developments.

03rd August, 2023

India needs to invest in protective gear ecosystem

Urgent need for enhanced infrastructure within the medical protective gear ecosystem in India cannot be overstated

02nd August, 2023

ChatGPT Redefines Medical Device As AI Medical Milestones : Dr. Dapeng Liu

In the ever-evolving world of AI, ChatGPT has emerged as a groundbreaking technology, capturing the attention of tech enthusiasts and industry experts alike

31st July, 2023

Unrivalled Precision of 12-Lead ECG

As individuals, we must make informed decisions and prioritise the use of 12-lead ECG devices for prevention and monitoring purposes

24th July, 2023

AACC Rebrands to the Association for Diagnostics & Laboratory Medicine

Association mission remains the same—better health through laboratory medicine.

24th July, 2023

Medtronic Board appoints Greg Lewis as new Director

Medtronic announced that its Board of Directors appointed Greg Lewis, Senior Vice President and Chief Financial Officer at Honeywell, to the Board. Lewis will serve on the Audit Committee and the Finance and Financial Risk Committee, effective June 26, 2023.

27th June, 2023